What is it about?
This review highlights the emerging role of new therapies in advanced lung cancer versus conventional treatment
Featured Image
Read the Original
This page is a summary of: Do we need Maintenance Chemotherapy in advanced NSCLC in the Era of Immune and Targeted Therapy?, Current Cancer Therapy Reviews, April 2018, Bentham Science Publishers,
DOI: 10.2174/1573394714666180417160205.
You can read the full text:
Contributors
The following have contributed to this page
